Search
for

    Sort by

    Research 781–810 of 1000+

    1. Correction to ‘Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study’ Journal of the European Academy of Dermatology and Venereology · 2025
    2. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial Contraception · 2009 · 42 citations
    3. Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis Journal of Pharmacy and Pharmacology · 2022 · 2 citations
    4. An open label, multi-center clinical trial of topical 5% minoxidil solution for the treatment of male androgenetic alopecia (a phase IV study) Journal of Clinical Dermatology · 2009 · 2 citations
    5. Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study Chinese Medical Journal · 2025
    6. 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset Journal of Investigative Dermatology · 2024
    7. The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial Journal of cachexia, sarcopenia and muscle · 2011 · 306 citations
    8. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial The Lancet · 2023 · 227 citations
    9. Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study Cancer Communications · 2021 · 147 citations
    10. Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer Journal of Clinical Oncology · 2022 · 9 citations
    11. Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial Clinical, Cosmetic and Investigational Dermatology · 2021 · 3 citations
    12. Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata” Journal of the American Academy of Dermatology · 2025 · 1 citations
    13. Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial Annals of Dermatology · 2025
    14. Comparison of a New 5% Minoxidil Foam and Rogaine® in the Treatment of Androgenetic Alopecia in Chinese Men: A Randomized, Double-Blind, Phase III, Equivalence Trial Dermatologic Therapy · 2023
    15. Short Anagen Syndrome Pediatric dermatology · 2010 · 28 citations
    16. FGF18 signaling determines radioresistance of telogen hair follicles by the arrest of hair cycling Journal of dermatological science · 2016
    17. Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2025
    18. High-performance liquid chromatographic determination of α-tocopheryl nicotinate in cosmetic preparations 1992 · 5 citations
    19. Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors Journal of Infection and Public Health · 2023 · 3 citations
    20. Molecular mediators involved in skin healing: a narrative review F1000Research · 2022 · 3 citations
    21. Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    22. The microfibrillar proteins of human hair: Separation by high-performance liquid chromatography and isolation of some proteins enriched in glycine and tyrosine Analytical Biochemistry · 1987 · 2 citations
    23. Spectrophotometric and Stability Indicating RP-HPLC-PDA method for Simultaneous Determination of Finasteride and Tamsulosin in Combined Tablet Dosage form Asian Journal of Research in Chemistry · 2009 · 1 citations
    24. Evaluation of hair growth promoting activity of petroleum ether extract of Abrus precatorius Linn. on Wistar Albino rats Journal of Drug Delivery and Therapeutics · 2019 · 1 citations
    25. Premature termination of hair follicle morphogenesis and accelerated hair follicle cycling in Iasi congenital atrichia (fz<sup>ica</sup>) mice points to <i>fuzzy</i> as a key element of hair cycle control Experimental dermatology · 2005 · 20 citations
    26. NF-κB Activity Is Required for Anagen Maintenance in Human Hair Follicles In Vitro Journal of Investigative Dermatology · 2014 · 15 citations
    27. Retrospective Review of Eyelash Number in Patients Who Have Undergone Full-Thickness Eyelid Resection Ophthalmic plastic and reconstructive surgery · 2014 · 3 citations
    28. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?]. PubMed · 1996 · 3 citations
    29. 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis Journal of Investigative Dermatology · 2019 · 1 citations
    30. Resolution of oxidative stress on dandruff scalps with Ayurvedic anti-dandruff regime: a clinical study International Journal of Research in Dermatology · 2026